While Journavx marks progress in non-opioid pain treatment, its modest effectiveness highlights the ongoing challenge of finding alternative pain relief solutions.
While Journavx marks progress in non-opioid pain treatment, its modest effectiveness highlights the ongoing challenge of finding alternative pain relief solutions.
Bisni Narayanan is the first South Asian-origin President of the CPA since its inception in 1876
Trupill’s Sid Viswanathan is back with a new pharmacy venture focused on HIV, Alchemy.
Tipirneni has been the CEO of Morphic since 2015.
The American Bazaar is a publication of American Bazaar, Inc., based in Germantown, MD.
